Broadcast One

Weds, March 5

  • London: 16.00
  • Paris: 17.00
  • Los Angeles: 8.00
  • New York: 11.00

Mitigating risk with materials data management

Smarter medical device development

This session has now passed: archived information follows.

Join this short webinar on Wednesday, March 5, to see how Granta's combination of tools and comprehensive, authoritative biological and material property data can support medical device companies.

  • See how you can access authoritative reference data on medical materials alongside corporate materials knowledge and project data, all via a single easy-to-use system.
  • Learn how the right materials information, in the right place, can help medical device enterprises to support compliance with restricted substance regulations such as REACH and the Dodd-Frank Act.
  • Understand how the GRANTA MI™ software can support materials information needs throughout the development cycle and across the organization.

What will be demonstrated at the webinar ?

The materials data that you generate in medical device development and regulatory approval is critical. You need the right data for design and decision-making, you need it up-to-date and accurate, and you need it deployed to designers and engineers in a secure, controlled, but easily usable manner. Quality processes such as ISO 13485 and Six Sigma demand that the quality of this data is fully understood, and that the data is “traceable”, so that any design decision can be audited. You also want to make sure that knowledge captured for one project is available for re-use in future projects. The webinar will discuss how GRANTA MI, the leading materials information management system for engineering enterprises, solves all of these problems.

GRANTA MI materials data management for medical device organizations

How the GRANTA MI software helps you manage materials knowledge for medical device organizations.

We will also be demonstrating Granta's authoritative reference data, including:

ASM Medical Materials combines engineering materials properties and biomedical response data with medical device application information for in-depth research into materials options during medical device design. It includes ~200 Orthopaedic materials, coatings, and drugs for all types of orthopaedic device, (including hips, knees, spinal, ankle, toe, elbow, finger, shoulder, wrist, and trauma), together with over 10,000 FDA device approvals, and over 200 Cardiovascular materials, coatings, and drugs (relevant to artificial hearts, bypass devices, clips, defibrillators, filters, grafts, heart valves, hemostasis devices, pacemakers, patches, stents, and vascular embolization devices) together with over 16,000 FDA device approvals.

The Critical Materials data module enables you to identify and understand supply risk for the materials used in your organization based on factors such as geopolitical risk, physical scarcity, conflict mineral risk, and price volatility. It is used for performing data-driven risk assessment of materials supply risks and taking mitigating action. For example, you can choose to avoid use of critical materials in design, find substitute materials, ensure stocks of key materials, and meet the reporting requirements of legislation such as the Dodd-Frank Act.

The Restricted Substances data module is a regularly updated information resource that helps you to understand your exposure to the legislation and standards that may restrict substances used in manufacturing your products. IT includes nearly 7,000 records, each describing a specific restricted substance, as well as the details of over 80 pieces of national and international legislation, regulations, and industry standards that regulate the use of such substances. New legislation is continually added and existing legislation is monitored and updated.

About the presenter

Dr Sarah Egan   Dr. Sarah Egan, Granta Design

Dr. Sarah Egan has led projects at Granta Design that have developed a series of innovative knowledge resources for medical device materials and, more recently, for human biological materials. Dr Egan's background in materials engineering for medical applications includes a PhD in Biomaterials from the University of Cambridge and an MEng in Materials Engineering in Medicine from Queen Mary College, University of London. As Medical Devices Product Manager at Granta she currently specializes in the compilation and application of materials data, the development and implementation of software for materials selection, and systems to enable materials information management in the medical device industry.

Who should join the web seminar?

Materials specialists and research engineers—learn how to increase productivity in testing and materials analysis, make more effective use of existing corporate materials information, and assess and manage regulatory risk.

Regulatory professionals—see tools to improve the efficiency of regulatory submissions and learn how your organization can 'design-out' materials-related regulatory risks, avoiding costly changes later in the development cycle.

Design engineering teams—see how you can access and apply reliable materials data to support design and simulation.

Senior managers of engineering, product development and design, or regulatory groups—find out how best practice materials information management can save time and cost, while reducing business risk.